Martin B. Brenner
2021
In 2021, Martin B. Brenner earned a total compensation of $1M as Chief Scientific Officer at iBio.
Compensation breakdown
| Bonus | $198,000 |
|---|---|
| Option Awards | $638,327 |
| Salary | $177,955 |
| Total | $1,014,282 |
Brenner received $638.3K in option awards, accounting for 63% of the total pay in 2021.
Brenner also received $198K in bonus and $178K in salary.
Rankings
In 2021, Martin B. Brenner's compensation ranked 8,754th out of 12,415 executives tracked by ExecPay. In other words, Brenner earned more than 29.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,754 out of 12,415 | 30th |
Division Manufacturing | 3,881 out of 5,508 | 30th |
Major group Chemicals And Allied Products | 1,714 out of 2,378 | 28th |
Industry group Drugs | 1,525 out of 2,099 | 27th |
Industry Pharmaceutical Preparations | 1,135 out of 1,549 | 27th |
Source: SEC filing on October 26, 2021.
Brenner's colleagues
We found two more compensation records of executives who worked with Martin B. Brenner at iBio in 2021.